Dose-Dense(dd) ABVD and Dose-Dense/Dose-Intense(dd-di) ABVD in Newly Diagnosed Patients (pts), Intermediate- and Advanced-Stage with Classical Hodgkin's Lymphoma (cHL): Final Results

被引：0
|
作者：
Russo, Filippo [1 ]
Corazzelli, Gaetano [2 ]
Lastoria, Secondo [3 ]
Marcacci, Gianpaolo [2 ]
Frigeri, Ferdinando [2 ]
Capobianco, Gaetana [2 ]
Becchimanzi, Cristina [2 ]
Arcamone, Manuela [2 ]
Pinto, Antonio [2 ]
机构：
[1] IRCSS, Fdn G Pascale, Ist Nazl Tumori, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
[2] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
[3] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Dept Nucl Med, Naples, Italy
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：298 / 299
页数：2
相关论文
共 37 条
  • [31] Final Report of a Phase-II Study of Rituximab Plus ABVD for Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma.: Results of Long Follow up and Comparison to Institutional Historical Data.
    Copeland, Amanda R.
    Cao, Yumei
    Fanale, Michelle
    Fayad, Luis
    McLaughlin, Peter
    Pro, Barbara
    Hagemeister, Fredrick
    Romaguera, Jorge
    Samaniego, Felipe
    Rodriguez, Alma
    Younes, Anas
    BLOOD, 2009, 114 (22) : 670 - 670
  • [32] Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Dickler, M. N.
    Traina, T.
    Panageas, K.
    Steingart, R.
    Dang, C.
    Fornier, M.
    Sugarman, S.
    Norton, L.
    Hudis, C.
    Rugo, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Incidence and severity of sensory neuropathy (SN) with bevacizumab (B) added to dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound (nab) paclitaxel (P) in patients (pts) with early stage breast cancer (BC)
    Sierecki, M. R.
    Rugo, H. S.
    McArthur, H. L.
    Traina, T. A.
    Paulson, M.
    Rourke, M.
    Norton, L.
    Seidman, A. D.
    Hudis, C. A.
    Dickler, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] DOSE-DENSE THERAPY WITH NON-PEGYLATED LIPOSOMAL DOXORUBICIN (R-COMP 14 VS. 21) IS FEASIBLE AND EFFECTIVE FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED AGGRESIVE B-CELL NON-HODGKIN LYMPHOMA
    Visani, G.
    Angrilli, F.
    Ferrara, F.
    Ilariucci, F.
    Falorio, S.
    Fioritoni, G.
    Alesiani, F.
    Brunori, M.
    Pollio, F.
    Celentano, M.
    Cangini, D.
    Ronconi, S.
    Catarini, M.
    Giglio, G.
    Vallisa, D.
    Arcari, A.
    Bernardi, D.
    Paolini, R.
    Guiducci, B.
    Barulli, S.
    Lucesole, M.
    Rocchi, M.
    Loscocco, F.
    D'Adamo, F.
    Isidori, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 287 - 287
  • [35] Circulating tumor cells (CTC) and circulating endothelial cells (CEC) in patients (pts) receiving adjuvant bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nab-paclitaxel (nab-P) for early-stage breast cancer (ESBC)
    Melisko, M. E.
    Greenberg, S.
    Dickler, M. N.
    Moasser, M. M.
    Scott, J. H.
    DeLuca, A. N.
    Moore, D. H.
    Hudis, C.
    Park, J. W.
    Rugo, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Phase 1 Results from a Phase 1/2 Study to Assess the Safety, Tolerability and Recommended Phase 2 Dose (RP2D) of Brentuximab Vedotin Plus Doxorubicin, Vinblastine and Dacarbazine (A plus AVD) in Pediatric Patients (Pts) with Advanced Stage Newly Diagnosed Classical Hodgkin Lymphoma (cHL)
    Franklin, Anna
    Zecca, Marco
    Fagioli, Franca
    Luisi, Flavio Augusto
    Song, Gregory
    Suri, Ajit
    Leonard, E. Jane
    Locatelli, Franco
    BLOOD, 2018, 132
  • [37] DOSE-DENSE THERAPY WITH NON-PEGYLATED LIPOSOMAL DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE AND RITUXIMAB (R-COMP) IS FEASIBLE AND EFFECTIVE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA: R-COMP 14 VS R-COMP 21. INTERIM ANALYSIS FROM AN ITALIAN MULTICENTE
    Visani, G.
    Ferrara, F.
    Merli, F.
    Angrilli, F.
    Ilariucci, F.
    Falorio, S.
    Fioritoni, G.
    Alesiani, F.
    Brunori, M.
    Pollio, F.
    Celentano, M.
    Cangini, D.
    Ronconi, S.
    Catarini, M.
    Giglio, G.
    Vallisa, D.
    Arcari, A.
    Bernardi, D.
    Guiducci, B.
    Barulli, S.
    Loscocco, F.
    Isidori, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 173 - 173
1234